Does ZANUBRUTINIB Cause Diffuse large b-cell lymphoma recurrent? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with ZANUBRUTINIB (BRUKINSA). This represents 0.3% of all adverse event reports for ZANUBRUTINIB.
7
Reports of Diffuse large b-cell lymphoma recurrent with ZANUBRUTINIB
0.3%
of all ZANUBRUTINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From ZANUBRUTINIB?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZANUBRUTINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ZANUBRUTINIB Cause?
Off label use (376)
Disease progression (224)
Contusion (165)
Myelosuppression (147)
Fatigue (146)
Rash (134)
Death (120)
White blood cell count decreased (119)
Platelet count decreased (112)
Anaemia (102)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which ZANUBRUTINIB Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
ZANUBRUTINIB vs ZAVEGEPANT
ZANUBRUTINIB vs ZEAXANTHIN
ZANUBRUTINIB vs ZELBORAF
ZANUBRUTINIB vs ZEMPLAR
ZANUBRUTINIB vs ZENATANE